Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[996]

This is a quote from the report of BMUR on Jiangbo. It is a paid report I don't have access too. But here you can find the next few lines
http://reports.finance.yahoo.com/w0?r=45457332:2

Jiangbo Pharmaceuticals, Inc. reported better-than-expected 3QFY09 revenue and pro forma EPS. Management raised its guidance and expected to meet or exceed its FY09 guidance. We believe that the company should be able to exceed its FY09 guidance range. The integration of Hongrui went well, and we believe that the acquisition should help the company generate solid growth over the next three years. At roughly 3.4x and 2.3x our FY10 and FY11 pro forma EPS estimates of $2.75 and $4.06, respectively, we...

For FY 2011 they expect earnings per share of approximately $ 4.06. Multiply that by 10~15 for a decent PE ratio and that gives a possible shareprice of $40~$60 !!! That reminds why I've put my money in this company...